Chemed Corp executive vice president sells $785,323 in stock

Published 03/03/2025, 21:32
Chemed Corp executive vice president sells $785,323 in stock

CINCINNATI—Spencer S. Lee, the executive vice president of Chemed Corp (NYSE:CHE), recently sold a significant portion of his holdings in the company. The $8.8 billion healthcare services company has seen its stock surge nearly 10% in the past week, with InvestingPro data indicating the stock is currently in overbought territory. According to a regulatory filing with the Securities and Exchange Commission, Lee sold 1,326 shares of Chemed’s capital stock on March 3, 2025. The shares were sold at a weighted average price of $592.25, amounting to a total transaction value of $785,323. Based on InvestingPro’s Fair Value analysis, the stock appears to be fairly valued at current levels.

The filing notes that the shares were sold in multiple transactions at prices ranging from $587.36 to $599.61. Following this sale, Lee retains ownership of 17,627 shares in the company. Despite this insider sale, InvestingPro analysis reveals management has been actively buying back shares, and the stock typically trades with low price volatility. Subscribers can access 12 additional ProTips and comprehensive analysis in the Pro Research Report.

In other recent news, Chemed Corporation reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an earnings per share (EPS) of $6.83, compared to the forecasted $6.78. The company’s revenue also exceeded projections, reaching $640 million against the anticipated $636.1 million. The VITAS Healthcare segment was a significant contributor, with a 17.4% increase in revenue year-over-year, despite a slight decline in the Roto Rooter segment’s revenue. Chemed has set its full-year 2025 EPS guidance between $24.95 and $25.45, up from $23.13 in 2024.

Additionally, Chemed’s recent acquisition of Covenant Health is meeting internal financial projections, contributing positively to the company’s performance. Analysts from RBC Capital Markets noted the company’s strong operating performance, particularly in the VITAS segment, which continues to show robust growth. The company anticipates continued expansion, especially in Florida, where it has been awarded a Certificate of Need in Marion County. Chemed’s management has also emphasized strategic initiatives to manage Medicare cap challenges, ensuring sustainable growth for VITAS.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.